11th Nov 2024 7:00 am |
RNS |
Institutional Investment |
30th Oct 2024 7:00 am |
RNS |
Schedule for Phase I Clinical Trial Opening |
2nd Oct 2024 11:19 am |
RNS |
Strategic Investment from Prevail Partners, LLC |
27th Sep 2024 7:00 am |
RNS |
Half-year Report |
9th Sep 2024 7:00 am |
RNS |
FLT3 Assay Ready for Phase I Trials at MD Anderson |
2nd Sep 2024 7:00 am |
RNS |
CDX Development Update |
28th Aug 2024 7:00 am |
RNS |
Presentation at CBD S&T Conference |
27th Jun 2024 4:39 pm |
RNS |
Result of Annual General Meeting |
17th Jun 2024 7:00 am |
RNS |
Operations Update |
3rd Jun 2024 7:00 am |
RNS |
Posting of Annual Report & Notice of AGM |
25th Apr 2024 7:00 am |
RNS |
Final Results |
28th Mar 2024 7:00 am |
RNS |
Total Voting Rights |
29th Feb 2024 7:00 am |
RNS |
Placing to Raise US$4.2 million |
16th Feb 2024 7:00 am |
RNS |
CBR Brain Delivery |
14th Feb 2024 7:00 am |
RNS |
CBR Intranasal Delivery |
9th Feb 2024 7:00 am |
RNS |
FDA Consents to Phase I Trials of HEMO-CAR-T |
2nd Feb 2024 7:00 am |
RNS |
Approval and Issuance of U.S. Conditioning Patent |
16th Jan 2024 7:00 am |
RNS |
Submission of Complete Response to Clinical Hold |
8th Jan 2024 7:00 am |
RNS |
HEMO-CAR-T Process Qualification Run Completed |
28th Nov 2023 12:19 pm |
RNS |
Placing to Raise £534,375 |
27th Nov 2023 7:00 am |
RNS |
CBR Expanded to Treatment of Cancer |
15th Nov 2023 7:00 am |
RNS |
Lentivirus Re-manufacturing Completed |
31st Oct 2023 7:00 am |
RNS |
Total Voting Rights |
28th Sep 2023 12:28 pm |
RNS |
Half-year Report |
18th Sep 2023 7:00 am |
RNS |
Strategic Investment from Prevail Partners, LLC |
14th Sep 2023 7:00 am |
RNS |
Clinical Hold Lift Plan is accepted by FDA |
8th Sep 2023 5:11 pm |
RNS |
CBR Patent Application Update |
10th Jul 2023 7:00 am |
RNS |
Full FDA Review for HEMO-CAR-T IND |
30th Jun 2023 4:07 pm |
RNS |
Result of Annual General Meeting |
2nd Jun 2023 2:01 pm |
RNS |
Posting of Annual Report & Notice of AGM |
2nd Jun 2023 11:24 am |
RNS |
Clinical Hold on IND for HEMO-CAR-T |
9th May 2023 7:00 am |
RNS |
Submission of IND for HEMO-CAR-T |
28th Apr 2023 10:05 am |
RNS |
Equity Incentive Pool Increase and Option Grant |
28th Apr 2023 7:00 am |
RNS |
Final Results for the Year Ended 31 December 2022 |
23rd Mar 2023 1:32 pm |
RNS |
HEMO-CAR-T Analytical Release Tests Completed |
28th Feb 2023 7:00 am |
RNS |
Total Voting Rights |
7th Feb 2023 2:30 pm |
RNS |
Admission of Shares to Official List |
26th Jan 2023 9:05 am |
RNS |
Second Price Monitoring Extn |
26th Jan 2023 9:00 am |
RNS |
Price Monitoring Extension |
26th Jan 2023 7:00 am |
RNS |
Placing to Raise £4,056,250 |